Background: Frailty increases vulnerability to adverse outcomes. Long-term conditions increase the risk of frailty. Methods: We searched PubMed, Web of Science, The Cochrane Library, EMBASE from inception to March 2022. Quality assessment was conducted using the NOS. Data was analysed in a pooled a random-effects meta-analysis. Our primary outcome was the impact of frailty on mortality in adults with Chronic Obstructive Pulmonary Disease (COPD) diagnosis according to the guidelines. Secondary outcomes were: frailty and association with readmissions, hospitalisations, exacerbation rates, and prevalence of frailty in COPD. Results: We identified 25 studies, with 5882 participants. The median prevalence of frailty was 47 (IQR, 39.3-66.3, range 6.4-72%). There was an association between COPD patients living with frailty and increased risk of mortality versus COPD patients without frailty (pooled OR,4.21 (95% CI 2.99-5.93, I2 55%). A descriptive analysis of relationship between frailty and hospital readmission and all cause hospitalization showed positive associations. The relationship between frailty and the risk of exacerbation showed a pooled OR, 1.45 (95% CI 0.37-5.70, I2 80%). Conclusion: Frailty is significantly associated with higher mortality risk in COPD. Frailty is common in patients with COPD and its measurement should be considered in clinical practice to better characterise COPD.

Frailty and its influence on mortality and morbidity in COPD: A systematic review and Meta-Analysis / Verduri, Alessia; Carter, Ben; Laraman, James; Rice, Ceara; Clini, Enrico; Maskell, Nick; Hewitt., Jonathan. - In: INTERNAL AND EMERGENCY MEDICINE. - ISSN 1970-9366. - 18:8(2023), pp. 2423-2434. [10.1007/s11739-023-03405-6]

Frailty and its influence on mortality and morbidity in COPD: A systematic review and Meta-Analysis.

Alessia Verduri;Enrico Clini;
2023

Abstract

Background: Frailty increases vulnerability to adverse outcomes. Long-term conditions increase the risk of frailty. Methods: We searched PubMed, Web of Science, The Cochrane Library, EMBASE from inception to March 2022. Quality assessment was conducted using the NOS. Data was analysed in a pooled a random-effects meta-analysis. Our primary outcome was the impact of frailty on mortality in adults with Chronic Obstructive Pulmonary Disease (COPD) diagnosis according to the guidelines. Secondary outcomes were: frailty and association with readmissions, hospitalisations, exacerbation rates, and prevalence of frailty in COPD. Results: We identified 25 studies, with 5882 participants. The median prevalence of frailty was 47 (IQR, 39.3-66.3, range 6.4-72%). There was an association between COPD patients living with frailty and increased risk of mortality versus COPD patients without frailty (pooled OR,4.21 (95% CI 2.99-5.93, I2 55%). A descriptive analysis of relationship between frailty and hospital readmission and all cause hospitalization showed positive associations. The relationship between frailty and the risk of exacerbation showed a pooled OR, 1.45 (95% CI 0.37-5.70, I2 80%). Conclusion: Frailty is significantly associated with higher mortality risk in COPD. Frailty is common in patients with COPD and its measurement should be considered in clinical practice to better characterise COPD.
2023
5-set-2023
18
8
2423
2434
Frailty and its influence on mortality and morbidity in COPD: A systematic review and Meta-Analysis / Verduri, Alessia; Carter, Ben; Laraman, James; Rice, Ceara; Clini, Enrico; Maskell, Nick; Hewitt., Jonathan. - In: INTERNAL AND EMERGENCY MEDICINE. - ISSN 1970-9366. - 18:8(2023), pp. 2423-2434. [10.1007/s11739-023-03405-6]
Verduri, Alessia; Carter, Ben; Laraman, James; Rice, Ceara; Clini, Enrico; Maskell, Nick; Hewitt., Jonathan
File in questo prodotto:
File Dimensione Formato  
Verduri (Frailty and mortality risk in COPD- review 2023).pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 1.02 MB
Formato Adobe PDF
1.02 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1315207
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact